USP19 and breast carcinoma: For all the reasons expressed before, we conclude that USP19 is relevant for the regulation of breast cancer cell dissemination and its expression levels correlate with a high risk of metastases development and could therefore represent a novel target for the management of breast cancer metastatic disease, in particular when LRP6 expression is relevant for determining patients’ outcome.